Ah‐Rong Nam

Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy

Hyerim Ha, Ah‐Rong Nam, Ju‐Hee Bang et al. · Oncotarget · 2016 · 97 citations · Full text

Immunology, Pathology, Cell Death +22

Therapeutic implication of HER2 in advanced biliary tract cancer

Ah‐Rong Nam, Ji‐Won Kim, Yongjun Cha et al. · Oncotarget · 2016 · 83 citations · Full text

Tumor Biology, Advanced Btc, Gastrointestinal Oncology +13

Phase II study assessing tolerability, efficacy, and biomarkers for durvalumab (D) ± tremelimumab (T) and gemcitabine/cisplatin (GemCis) in chemo-naïve advanced biliary tract cancer (aBTC).

Do‐Youn Oh, Kyung-Hun Lee, Dae‐Won Lee et al. · Journal of Clinical Oncology · 2020 · 79 citations

Immunology, Pathology, Phase Ii Study +18

Inhibition of ATR Increases the Sensitivity to WEE1 Inhibitor in Biliary Tract Cancer

Ah‐Rong Nam, Meihua Jin, Ju‐Hee Bang et al. · Cancer Research and Treatment · 2020 · 21 citations · Full text

The prognostic role of soluble TGF‐beta and its dynamics in unresectable pancreatic cancer treated with chemotherapy

Hyunkyung Park, Ju‐Hee Bang, Ah‐Rong Nam et al. · Cancer Medicine · 2019 · 16 citations · Full text